PlainHospital
2026 data FDA MAUDE openFDA FDA Class III

Acid, Hyaluronic, Intraarticular

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

Browse devices → Device safety hub

FDA MAUDE casebook

openFDA event book Acid, Hyaluronic, Intraarticular LIGHT-BOOK · MAUDE

#239 of 1000 · 8,410 reports · 1997–2026

  • BOOK 8,410 reports
  • RANK #239 of 1000
  • DEATH 307 death-typed
  • INJ 5,581 injury-typed
  • MALF 678 malfunction
  • SPAN 1997–2026
  • PEAK 2018: 1,099
  • PHOTO Abutment

Nearest event-volume peer: Abutment, Implant, Dental, Endosseous (1 report gap)

Acid, Hyaluronic, Intraarticular sits #239 of 1000 among tracked device types with 8,410 MAUDE reports spanning 1997–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Similar-volume device →

Malfunction reports sit below the device-type norm

Acid, Hyaluronic, Intraarticular carries 8.1% MALFUNCTION-coded reports, 56.8pp below the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 3.7% corpus 1.5% · above corpus mean (+2.1 pp)
  • INJ 66.4% corpus 30.3% · above corpus mean (+36.1 pp)
  • MALF 8.1% corpus 64.8% · below corpus mean (-56.8 pp)

Lead product-problem code Adverse Event Without Identified Device or Use Problem is 37% of coded problems · Top event location is 49% of location-tagged rows .

Acid, Hyaluronic, Intraarticular in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Acid, Hyaluronic, Intraarticular carries 8,410 MAUDE reports, ranked #239 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Injury 5,581 (66.4%)
Other 1,437 (17.1%)
Malfunction 678 (8.1%)
407 (4.8%)
Death 307 (3.7%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 2,847 (26.4%)
Other 2,401 (22.2%)
Hospitalization 1,485 (13.7%)
R 1,343 (12.4%)
820 (7.6%)
O 488 (4.5%)
Disability 476 (4.4%)
S 423 (3.9%)
Death 309 (2.9%)
H 95 (0.9%)
L 54 (0.5%)
Life Threatening 47 (0.4%)
D 11 (0.1%)
Congenital Anomaly 2 (0.0%)

Top Product Problems

Adverse Event Without Identified Device or Use Problem 3,132
Insufficient Device Problem Information 1,976
Patient-Device Incompatibility 772
Device Contamination With Biological Material 536
Unknown (for use when the device problem is not known) 514
Device Operates Differently Than Expected 242
Device remains implanted 219
Microbial Contamination of Device 180
Reaction 146
Off-Label Use 121
Nonstandard Device 99
Appropriate Device Problem Term/Code Not Available 90
Improper or Incorrect Procedure or Method 73
Use of Device Problem 58
Break 46
Patient Device Interaction Problem 41
Therapeutic or Diagnostic Output Failure 41
No Apparent Adverse Event 37
Unexpected Therapeutic Results 24
Contamination 20

Yearly Trend

97
1997: 9
98
1998: 34
99
1999: 16
00
2000: 29
01
2001: 37
02
2002: 72
03
2003: 88
04
2004: 132
05
2005: 123
06
2006: 130
07
2007: 132
08
2008: 222
09
2009: 315
10
2010: 323
11
2011: 385
12
2012: 462
13
2013: 637
14
2014: 340
15
2015: 293
16
2016: 313
17
2017: 506
18
2018: 1,099
19
2019: 567
20
2020: 441
21
2021: 375
22
2022: 305
23
2023: 470
24
2024: 292
25
2025: 185
26
2026: 78

Reports fell to 185 in 2025, down from an average of 381 in the two years before.

Related Entities for Acid, Hyaluronic, Intraarticular

Event Locations

4,151 (49.4%)
I 2,424 (28.8%)
NO INFORMATION 850 (10.1%)
OUTPATIENT TREATMENT FACILITY 424 (5.0%)
OTHER 178 (2.1%)
HOME 153 (1.8%)
HOSPITAL 112 (1.3%)
INVALID DATA 69 (0.8%)
UNKNOWN 43 (0.5%)
NURSING HOME 2 (0.0%)
OUTPATIENT DIAGNOSTIC FACILITY 2 (0.0%)
AMBULATORY SURGICAL FACILITY 1 (0.0%)
PUBLIC VENUE 1 (0.0%)

Nationwide devices with a comparable volume-and-death footprint

Two openFDA-derived peer sets for Acid, Hyaluronic, Intraarticular: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (8,410 here).

Abutment, Implant, Dental, Endosseous 8,409 Dialyzer, Capillary, Hollow Fiber 8,424 Hysteroscope 8,394 Catheter, Peripheral, Atherectomy 8,451

Similar death-typed counts

Nearest other device types by death-typed report count (307 here), distinct from the volume row.

Catheter 307 Set 307 Catheter, Hemodialysis, Implanted 301 Catheter 300

Read our methodology - how this data is sourced, computed, and verified.

Disclaimer: MAUDE figures for Acid, Hyaluronic, Intraarticular are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Acid, Hyaluronic, Intraarticular; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.